News & Analysis as of

Tariffs › Executive Orders › Inflation Reduction Act (IRA)

Faegre Drinker Biddle & Reath LLP

The Effects of HHS Workforce Reductions, Tariffs on Pharma, the ‘Pill Penalty’ and More

Faegre Drinker Biddle & Reath LLP on

With the rapidly evolving regulatory landscape, staying on top of the latest updates is crucial for companies in biopharma and medical devices. In this briefing, we highlight recent regulatory and legislative developments...more

Latham & Watkins LLP

Healthcare Life Sciences Drug Pricing Digest - April 2025 #2

Latham & Watkins LLP on

On April 15, 2025, President Trump signed an executive order titled “Lowering Drug Prices by Once Again Putting Americans First.” The order includes various provisions that are relevant to the pharmaceutical industry,...more

ArentFox Schiff

Five Hot (Sizzling) Button Trade Issues for the Electric Mobility Industry in 2025

ArentFox Schiff on

The electric mobility industry faces significant challenges, to be sure. With the Inflation Reduction Act (IRA) of 2022 in peril, leaner times may be ahead....more

Kilpatrick

Kilpatrick Federal Update – Federal Funding Terminations, Tariffs, and Tax Credits: Key Considerations and What You Can Do

Kilpatrick on

It has been just over a month since President Trump assumed office, and while the Administration's policy landscape remains dynamic, three critical areas have emerged with significant implications for businesses and...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide